El mercado de anticuerpos personalizados se valoró en 833,71 millones de dólares en 2028, frente a 409,26 millones de dólares en 2021; se estima que crecerá a una tasa compuesta anual del 10,7 % entre 2021 y 2028.
Se pueden generar anticuerpos personalizados en un ratón, rata o hámster para adaptarse a cualquier huésped. requisitos. Las empresas proporcionan una amplia gama de anticuerpos según las necesidades del investigador. Existe una variedad de anticuerpos personalizados en el mercado que incluyen anticuerpos policlonales y monoclonales, anticuerpos monoclonales recombinantes, anticuerpos de hibridoma, anticuerpos policlonales recombinantes y otros. Las empresas ofrecen servicios de soporte completos para todos los tipos y pasos de producción de anticuerpos, desde el diseño de péptidos, la síntesis y la conjugación de proteínas transportadoras hasta la inmunización animal, la recolección de suero o la fusión de hibridomas, el análisis de títulos y la purificación final de anticuerpos.
El crecimiento del mercado de anticuerpos personalizados se atribuye a factores como la alta demanda en investigación, el creciente apoyo de los gobiernos y las enfermedades en continuo cambio. Los perfiles de empresas, el aumento de las alianzas público-privadas y el aumento de las actividades de financiación están mejorando ampliamente el desempeño de la biotecnología. Sin embargo, la producción de anticuerpos monoclonales y policlonales varía según los animales que se utilizan para obtenerlos. El costo también está determinado por los paquetes de anticuerpos personalizados demandados para diferentes aplicaciones que ofrecen diferentes actores, lo que dificulta el crecimiento del mercado.
regiones lucrativas para el mercado de anticuerpos personalizados
Perspectivas del mercado
Servicios de producción y desarrollo ofrecidos por proveedores de anticuerpos personalizados
Varias empresas ofrecen agresivamente servicios de investigación y desarrollo de anticuerpos personalizados. A continuación se mencionan algunos de los servicios lanzados por estas empresas.
- En junio de 2021, GenScript anunció el lanzamiento de su MonoRab, un servicio personalizado de anticuerpos monoclonales de conejo (mAB). Se agrega a la cartera de servicios integrados de anticuerpos premium de la empresa. MonoRab es la tecnología patentada de la empresa que utiliza la combinación de tecnologías de hibridoma y secuenciación de anticuerpos monoclonales en etapa temprana. Ambas tecnologías ofrecen mAb de conejo personalizados que son más específicos y poseen mayor afinidad, así como las capacidades diversificadas necesarias para una amplia gama de aplicaciones.
- En marzo de 2021, Giotto Biotech lanzó servicios especializados de producción de anticuerpos policlonales y monoclonales. La empresa facilita la producción de más de 500 tipos de anticuerpos monoclonales que pueden utilizarse para aplicaciones diagnósticas y terapéuticas. Ofrece una gran variedad de especies como fuentes de anticuerpos policlonales.
- En noviembre de 2020, AMSBIO anunció servicios de desarrollo de anticuerpos monoclonales recombinantes de conejo y ratón. El desarrollo de anticuerpos monoclonales recombinantes se basa en la plataforma de desarrollo DimAb, que es diferente de las tecnologías de fusión de hibridomas convencionales. Tiene capacidad para aislar genes IgG de células B de animales inmunizados. Estos anticuerpos ayudan en el desarrollo y comercialización de fármacos en el mercado. En octubre de 2019, la FDA aprobó el primer fármaco derivado de anticuerpos monoclonales de conejo: Beovu. Beovu está destinado a tratar la degeneración macular húmeda relacionada con la edad (DMAE).
- En marzo de 2020, Absolute Antibody Ltd anunció el lanzamiento de un servicio de producción de anticuerpos recombinantes de alto rendimiento para su FleXpress. La empresa ofrece a sus clientes servicios para facilitar la expresión rápida de muchos anticuerpos, hasta un volumen de 80 ml, así como para impulsar la capacidad de producción para satisfacer la creciente demanda de tecnología de anticuerpos recombinantes.
Estos servicios de producción de anticuerpos personalizados que ofrecen las empresas están acelerando el crecimiento del mercado.
Información basada en servicios
Basada en el servicio , el mercado de anticuerpos personalizados se segmenta en desarrollo de anticuerpos, producción y purificación de anticuerpos, y fragmentación y etiquetado de anticuerpos. En 2020, el segmento de desarrollo de anticuerpos tuvo la mayor participación del mercado y se estima que crecerá a una tasa compuesta anual significativa durante el período de pronóstico.
Mercado de anticuerpos personalizados, por servicio - 2020 y 2028
Información basada en tipos
Según el tipo, el mercado de anticuerpos personalizados se segmenta en anticuerpos monoclonales , anticuerpos policlonales y otros anticuerpos personalizados. En 2020, el segmento de anticuerpos monoclonales tuvo la mayor participación del mercado, mientras que se espera que el segmento de anticuerpos policlonales crezca durante el período de pronóstico.
Información basada en fuentes< /p>
Según la fuente, el mercado de anticuerpos personalizados está segmentado en ratones, conejos y otros. El segmento de ratones tuvo la mayor participación de mercado en 2020, mientras que se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.
Área de investigación Insights basados en
Según el área de investigación, el mercado de anticuerpos personalizados se segmenta en oncología, inmunología, células madre, enfermedades infecciosas, neurobiología, enfermedades cardiovasculares y otras. El segmento de oncología tuvo la mayor participación del mercado en 2020, mientras que se prevé que el segmento de células madre registre la CAGR más alta del mercado durante el período de pronóstico.
Fin Información basada en los usuarios
Basado en los usuarios finales, el mercado de anticuerpos personalizados se segmenta en empresas farmacéuticas y de biotecnología, institutos académicos y de investigación, y organizaciones de investigación por contrato. En 2020, el segmento de empresas farmacéuticas y biotecnológicas tuvo la mayor participación del mercado y se espera que crezca al ritmo más rápido durante los próximos años.
Perspectivas estratégicas
Los lanzamientos y aprobaciones de productos son las estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. Además, los actores del mercado de la reconstrucción mamaria se centran en la estrategia de colaboración para ampliar su clientela, lo que, a su vez, les permite mantener su marca a nivel mundial.
Por servicio< /h3>- Desarrollo de anticuerpos
- Producción y purificación de anticuerpos
- Fragmentación y etiquetado de anticuerpos
Por tipo
- Anticuerpos monoclonales
- Anticuerpos policlonales
- Otros anticuerpos personalizados
Por fuente
- Ratones
- Conejos
- Otros
Por área de investigación
- Oncología
- Inmunología
- Células madre
- Enfermedades infecciosas
- Neurobiología
- Enfermedades cardiovasculares
- Otras
Por usuarios finales
- Empresas farmacéuticas y de biotecnología
- Institutos académicos y de investigación
- Organizaciones de investigación por contrato
Por geografía
- América del Norte
- Estados Unidos
- Canadá
- México
- Europa
- Francia
- Alemania
- Italia
- Reino Unido
- España
< li>Resto de Europa
- Estados Unidos
- Canadá
- México
- Francia
- Alemania
- Italia
- Reino Unido
- España < li>Resto de Europa
- China
- India
- Corea del Sur< /li>
- Japón
- Australia
- Resto de Asia Pacífico
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de Oriente Medio y África
- Brasil
- Argentina
- Resto de América del Sur y Central
Perfiles de la empresa
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Tecnología de señalización celular, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Customized antibodies can be generated in a mouse, rat or hamster, to meet any particular host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
The growth of the market is attributed to some key driving factors such as the high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology. For instance, In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors. Such strategic steps are also projected to drive the market growth.
The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the custom antibody market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology growth of Europe custom antibody market during the forecast period.
The List of Companies - Custom Antibody Market
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)